Photodynamic therapy (PDT) is a two-stage treatment that implies the use of light energy,
oxygen, and light-activated compounds (photosensitizers) to elicit cancerous and …

Fluorescence imaging in the second near‐infrared window (NIR‐II, 1000–1700 nm) has
aroused immense attention for biomedical applications, offering exceptional advantages …

Hypoxia, a prominent hallmark of hepatocellular carcinoma (HCC), undermines curative
outcomes, elevates recurrence rates, and fosters metastasis, particularly during …

Currently three major problems seriously limit the practical application of cancer
photodynamic therapy (PDT):(i) the hypoxic tumor microenvironment (TME);(ii) low …

Photo-assisted tumor therapy, encompassing photodynamic therapy (PDT) and
photothermal therapy (PTT), has garnered considerable attention as a promising approach …

Develo** Type‐I photosensitizers provides an attractive approach to solve the dilemma of
inadequate efficacy of photodynamic therapy (PDT) caused by the inherent oxygen …

A planar conjugated ligand functionalized with bithiophene and its Ru (II), Os (II), and Ir (III)
complexes have been constructed as single‐molecule platform for synergistic …

Cancer, with its diversity, heterogeneity, and complexity, is a significant contributor to global
morbidity, disability, and mortality, highlighting the necessity for transformative treatment …

Osteoarthritis (OA) is a prevalent, chronic degenerative disease that affects people
worldwide. It is characterized by the destruction of cartilage and inflammatory reactions …

Hypoxia, as a distinctive feature of tumors, is closely related to tumor recurrence, metastasis,
and treatment resistance. Metal–organic framework (MOF) exhibits an increasing number of …